3rd Quarter - Report

MARSHALL & POPP, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.3512/S.1821 - Tackling Predatory Litigation Funding Act.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL —
MONICA POPP —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1821 (119th), H.R. 3512 (119th)

Defense DEF

Issues related to TRICARE coverage of diabetes management devices.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL —
MONICA POPP —

Contacted: SENATE

Health Issues HCR

Proposals related to colorectal cancer screening.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL —
MONICA POPP —

Contacted: SENATE

Trade (domestic/foreign) TRD

Proposals related to tariffs on products imported into the United States.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL —
MONICA POPP —

Contacted: SENATE

Agriculture AGR

Issues related to infant formula, including H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and S.4940 - Specialized Infant Formula Act.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles
MONICA POPP Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2300 (119th), S. 4940 (119th)

Medicare/Medicaid MMM

Proposals related to Medicare coverage of continuous glucose monitors. Issues related to cancer diagnostics national coverage determination.

LobbyistCovered position, as disclosed
HAZEN CLAY MARSHALL —
MONICA POPP —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.